• Sat. Jun 3rd, 2023

Biologics and Biosimilars: A Test for Intellectual Property

By

Feb 6, 2023
The fundamental tradeoff of intellectual property rights–like patents and copyrights–is that the inventor gets a government-protected monopoly for a period of time, as an incentive for innovation, but then the innovation passes into the public domain. For example, this is the moment when generic equivalents of pharmaceuticals can start competing with brand-name drugs.

Read More